Children with recurrent brain tumours tolerated the first in-human trial of a novel immunotherapy well, and many were able to experience unexpected months of a more normal life, according to researchers. Immunotherapy disables a natural enzyme that tumours hijack for their defence.
A therapeutic tool focused on emotional awareness that increased activation and connectivity of an emotion-regulating centre in the brain has been discovered by researchers. The therapy may be useful in the long-term treatment and prevention of relapse in bipolar disorder (BD).
According to the results of a Cancer Research UK-funded clinical trial, giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back.
Glioblastoma is the most lethal and malignant adult brain cancer that may arise from the neuroglial stem or progenitor cells. Certain gene mutations or those with a known history of other cancers and radiation therapy may predispose patients to develop brain cancer. Tumour relapse is invaria
Approximately 70 per cent of breast cancer cases are hormonally driven, and treatment involves oral oestrogen blockers. However, the medications can induce joint pain, which is why many women stop taking them, placing them at an increased risk of relapse.
Researchers found and developed nanoparticles that simultaneously carry chemotherapy and a new immunotherapy. Chemotherapy is a pillar of cancer treatment, but residual cancer cells can persist and cause tumor relapse.
With over 2 million new cases each year, colon cancer is the third most prevalent disease in the world. The majority of patients receive their diagnosis while the tumour is still in the colon or rectum.
The study discovered new treatments that can assist patients with multiple myeloma, a blood cancer, who have tried the immunotherapy CAR-T but have experienced relapses.
Bentley was arrested in 2008 and pleaded guilty to heroin possession. He was ordered into counselling and 12-step programs but continued to relapse and use heroin until he was broke.
Researchers have identified therapies that can help patients with multiple myeloma blood cancer who try an immunotherapy known as CAR-T only to find their cancer returning afterwards.